All products / DC9445
Ozagrel (sodium)
Pack sizes and prices
| Pack size | Price |
|---|---|
| 100 mg | $150 USDRequest a quote → |
| 250 mg | $300 USDRequest a quote → |
| 1 g | $600 USDRequest a quote → |
In stock. Contact our team for lead time, shipping and final quotation.
Product overview
Ozagrel(OKY-046) sodium salt is an antiplatelet agent working as a thromboxane A2 synthesis inhibitor. Ozagrel was selected as the best compound of highly selective inhibitors of TXA2 synthase. The inhibition of TXA2 synthase by ozagrel was more effective on human and rabbit enzymes than those of other species. Ozagrel increased 6-keto-PGF1 alpha, one of stable metabolites of PGI2, in various isolated cells and tissues perhaps via accumulated PG endoperoxides resulted by the inhibition of TXA2 synthase. Ozagrel was estimated to be a reversible mixed-type inhibitor of diphenolase activity with the constants (K (S1), K (S2), K (i1), and K (i2)) determined to be 2.21, 3.89, 0.454, and 0.799 mM, repectively. Infusion of OKY-046 significantly inhibited pulmonary thromboxane B2 delivery, attenuated the early increase in pulmonary vascular resistance, and blocked the increase in systemic vascular resistance. In addition, OKY-046 blunted and delayed the decrease in cardiac output and maintained end-systolic pressure-diameter relation, +dp/dt, and lung lymph flow at baseline values.
For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.
Identity and specifications
| Catalog number | DC9445 |
|---|---|
| Product name | Ozagrel (sodium) |
| CAS | 130952-46-4 |
| Molecular formula | C13H11N2NaO2 |
| Molecular weight | 250.2284 |
| Purity | >98% |
| SMILES | O=C([O-])/C=C/C1=CC=C(CN2C=CN=C2)C=C1.[Na+] |
Source-listed specifications; the batch COA applies.
Source and product documents
The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.
DC Chemicals — Ozagrel (sodium) (DC9445)